| 2025 | 2024 | 2023 | 2022 | 2021 | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 104,8 k € | +115.0% | 48,7 k € | +392.4% | -16,7 k € | -40.4% | -11,9 k € | -127.5% | 43,1 k € | |
| EBITDA | 19,1 k € | +7.1% | 17,8 k € | +201.6% | -17,6 k € | -44.7% | -12,1 k € | -128.5% | 42,6 k € | |
| Operating profit | 4,2 k € | -32.8% | 6,3 k € | +126.3% | -24,0 k € | -73.3% | -13,8 k € | -135.2% | 39,3 k € | |
| Profit/loss | 1,6 k € | -67.5% | 4,8 k € | +118.8% | -25,5 k € | -72.9% | -14,7 k € | -144.4% | 33,2 k € | |
| Equity | 1,3 k € | +592.4% | -262,1 € | +94.8% | -5,0 k € | -124.7% | 20,4 k € | -41.9% | 35,2 k € | |
| Total assets | 170,5 k € | +72.0% | 99,1 k € | +6.5% | 93,1 k € | +57.2% | 59,2 k € | -39.9% | 98,4 k € | |
| Cash | 76,4 k € | +226.8% | 23,4 k € | -51.5% | 48,2 k € | +212.0% | 15,5 k € | -79.8% | 76,6 k € | |
| Debts | 169,2 k € | +70.2% | 99,4 k € | +1.3% | 98,1 k € | +153.2% | 38,7 k € | -38.7% | 63,2 k € | |
Private limited company · Gent · incorporated on 29/09/2020
Private limited company profitable and well capitalised. Cash position rising (+226.8%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
MAYAKU PHARMACEUTICAL DEVELOPMENT is a Private limited company incorporated in 2020. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Gent.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.